HomeAI · summaries
Storia in 7 fonti
Democrats press White House on who got special access to Eli Lilly’s new obesity drug
The unusual access to an experimental drug has captured the attention of the American public as well.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
forbes.com
White House Denies Trump Was Given Exclusive Weight Loss Drug
A report from STAT News said Eli Lilly and the FDA gave a 79-year-old man exclusive access to the drug after a request for it was made in April.
- ·
newrepublic.com
Eli Lilly Approved Obesity Drug for Mystery 79-Year-Old Patient
Questions are swirling over Donald Trump’s health after a bombshell report revealed a mystery man was getting unprecedented access to a weight-loss drug.
- ·
Remember That Time Trump Said He “Probably Should” Take Ozempic?
A bombshell report about how a 79-year-old man got early access to a weight loss drug has all eyes on the president.
- ·
statnews.com
Eli Lilly gave extraordinary obesity drug access to a 79-year-old patient. Who was it?
Exclusive: STAT has learned that Eli Lilly and the FDA allowed a 79-year-old to gain extraordinary access to an experimental obesity drug through the agency’s “compassionate use”…
- ·
Exclusive: Mystery man gets experimental GLP-1
Giving an individual special access to an experimental obesity drug is highly unusual.
- ·
gizmodo.com
Just Who Is the Mystery 79-Year-Old Patient Who Got Special Access to an Experimental Weight Loss Drug?
The White House has denied that the application was filed on behalf of President Donald Trump.
- ·
independent.co.uk
White House denies Trump is the mystery patient who got early access to obesity drug
A White House spokesman said theories that President Trump sought the drug were ‘baseless speculation’
- ·
nymag.com
Did Trump Get Early Access to Eli Lilly’s New Weight-Loss Drug?
The FDA let one 79-year-old take an experimental obesity drug. That sure sounds like the president, but let’s examine the evidence.
- ·
Is Trump on an Experimental Weight Loss Drug? An Investigation.
The FDA gave one well-connected 79-year-old early access to Eli Lilly’s new drug. Its sure sounds like the president, but let’s examine the evidence.
- ·
White House denies Trump was mystery patient given early access to weight-loss drug
Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.AllNewsSportCultureLifestyleWhite House officials are denying that…
- ·
benzinga.com
White House Denies Report Linking Trump To Eli Lilly's Experimental Obesity Treatment: 'Not For The Presi
White House denies reports Trump received Eli Lilly's unapproved obesity drug retatrutide through an FDA program.
- ·
Democrats press White House on who got special access to Eli Lilly’s new obesity drug
The unusual access to an experimental drug has captured the attention of the American public as well.